Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular weight loss drug Wegovy through new channels.

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

PEMBROKE PARK, Fla. – Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

FRANKFURT: European shares extended gains to a sixth session on Tuesday, with financials giving support following earnings ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

Stocks closed higher Tuesday to extend a week-long rally as investors digested a flurry of earnings reports from major ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy. | Novo Nordisk and Hims & Hers have struck a truce after sparring over ...

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and ...

Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo ...